Andere talen Cerus Corporation

Aandelen

CERS

US1570851014

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,71 ^USD	+0,59%		+1,18%	-20,83%

12/04	CERUS CORPORATION : Craig-Hallum handhaaft koopadvies	ZM
26/03	Cerus Corporation kondigt FDA-goedkeuring van verlengde houdbaarheid voor INTERCEPT-bloedplaatjesverwerkingssets aan - verdubbeling van de vorige houdbaarheidstermijn	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024	18/04
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets, Doubling Previous Shelf Life	27/03
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life	26/03
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets - Doubling Previous Shelf Life	26/03
Cerus Says Intercept Blood System Meets Non-Inferiority Goal in Phase 3 Study; Shares Rise	19/03
Cerus Shares Rise on Positive Results for Intercept Blood Cells Trial	19/03
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients	19/03
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients	19/03
Cerus Insider Sold Shares Worth $256,377, According to a Recent SEC Filing	15/03
Cerus: Q4 Earnings Snapshot	05/03
Cerus Reiterates Full Year 2024 Product Revenue Guidance of $172-$175 Million	05/03
Earnings Flash (CERS) CERUS CORPORATION Reports Q4 Revenue $53.3M, vs. Street Est of $52M	05/03
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results	05/03
Cerus Corporation Reiterates Product Revenue Guidance for the Full Year 2024	05/03
Cerus Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
Microsize Announces Expanded CDMO Relationship with Cerus Corporation	27/02
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024	20/02
Cerus Corporation to Participate in Upcoming Investor Conferences	01/02
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update	08/01
Cerus Corporation Reports Unaudited Preliminary Revenue Results for the Fourth Quarter and Full-Year 2023	08/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cerus Corporation

Aandelen

CERS

US1570851014

Andere talen

Filters